These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 12466322)
1. The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors. Koch CA; Pacak K; Chrousos GP J Clin Endocrinol Metab; 2002 Dec; 87(12):5367-84. PubMed ID: 12466322 [TBL] [Abstract][Full Text] [Related]
2. The molecular pathogenesis of childhood adrenocortical tumors. Almeida MQ; Latronico AC Horm Metab Res; 2007 Jun; 39(6):461-6. PubMed ID: 17578765 [TBL] [Abstract][Full Text] [Related]
3. Insights into the role of genetic alterations in adrenocortical tumorigenesis. Herbet M; Feige JJ; Thomas M Mol Cell Endocrinol; 2009 Mar; 300(1-2):169-74. PubMed ID: 19007854 [TBL] [Abstract][Full Text] [Related]
11. New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas. Bertherat J; Gimenez-Roqueplo AP Horm Metab Res; 2005 Jun; 37(6):384-90. PubMed ID: 16001332 [TBL] [Abstract][Full Text] [Related]
12. Adrenocortical tumorigenesis in transgenic mice: the role of luteinizing hormone receptor and transcription factors GATA-4 and GATA-61. Rahman NA; Kiiveri S; Siltanen S; Levallet J; Kero J; Lensu T; Wilson DB; Heikinheimo MT; Huhtaniemi IT Reprod Biol; 2001 Jul; 1(1):5-9. PubMed ID: 14666170 [TBL] [Abstract][Full Text] [Related]
13. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors. Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815 [TBL] [Abstract][Full Text] [Related]
14. [Morphological typing, evaluation of tumor dignity and prognosis and etiologic classification of adrenomedullary and adrenocortical neoplasias]. Schröder S; Komminoth P; Padberg B; Heitz PU Pathologe; 1995 Sep; 16(5):307-14. PubMed ID: 7479602 [TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs in adrenal tumors. Igaz P Curr Opin Endocrinol Diabetes Obes; 2019 Jun; 26(3):155-159. PubMed ID: 30801265 [TBL] [Abstract][Full Text] [Related]
16. Molecular markers and the pathogenesis of adrenocortical cancer. Soon PS; McDonald KL; Robinson BG; Sidhu SB Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740 [TBL] [Abstract][Full Text] [Related]
17. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927 [TBL] [Abstract][Full Text] [Related]
18. [Sporadic adrenocortical tumors: genetics and perspectives for the pathologist]. Tissier F Ann Pathol; 2008 Oct; 28(5):409-16. PubMed ID: 19068395 [TBL] [Abstract][Full Text] [Related]